Solid Biosciences' DMD gene therapy shows promise with SGT-003 and strong cash backing through 2027. Click here to read an ...

Ultragenyx (RARE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

The draft is done. So is development camp. Free agency — never much of a frenzy to begin with — has mostly wrapped up, too.

The deal gives AstraZeneca’s rare disease unit Alexion access to specialized capsids developed by the Japanese biotech JCR ...

Fintel reports that on July 11, 2025, B of A Securities initiated coverage of Taysha Gene Therapies (NasdaqGS:TSHA) with a ...

CIBC’s Canadian REITs Monthly report focused on the confusion caused by tariffs, ...

Investing.com -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) stock surged 22% after the company announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its ...

Merck & Co. Inc. has strengthened its cardiopulmonary pipeline with its $10 billion acquisition of London-based-Verona Pharma plc. The deal brings Merck Ohtuvayre (ensifentrine) for chronic ...

Robbins Geller files suit against Rocket Pharma over undisclosed trial risks tied to RP-A501. Lead plaintiff deadline: August ...

When the player-elected arbitration deadline passed yesterday, only Jayden Struble elected to use that course of action. Jakub Dobes was eligible for it, but he didn’t file. It turns out he didn’t ...